News
Aiforia Announces Closing of €17.5M Series B Funding Round
Financing to accelerate Aiforia’s development and continuing expansion of AI solutions for image analysis in clinical diagnostics and preclinical pathology.
Helsinki, Finland
September 16, 2021
Aiforia, a software company providing AI-based solutions for clinical diagnostics and preclinical analysis to enable pathologists to translate medical images into diagnoses and discoveries with more efficiency and precision, announced today the completion of a €17.5M Series B funding round. The funding round is led by Epredia's UK entity, a subsidiary of PHC Holdings Corporation.
The funding helps accelerate the development and commercialization of Aiforia’s portfolio of clinical tools for AI-assisted support in the diagnosis of some of the world’s most prevalent diseases like breast and lung cancer — Aiforia intends to launch CE-IVD marked clinical tools for both diseases this year.
Aiforia also seeks to expand upon its highly versatile and scalable cloud-based tools and services for preclinical assessment, such as in pharmaceutical drug development. Additionally, Aiforia aims to continue investing in hiring top talent to further build on its scientific and technical support teams as well as its commercial team.
"Aiforia has made great progress recently, such as the CE-IVD marking of the Aiforia™ Clinical AI Model for Breast Cancer: Ki67, a widely used key biomarker in breast cancer diagnostics, we are excited to continue this momentum with our product offering, to meet the demands of increasing volumes of patient samples and the need for quantitative, standardized data in pharmaceutical drug development."
- Jukka Tapaninen, CEO, Aiforia.
Find out more about Aiforia at www.aiforia.com
About Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence and cloud-based technology to improve the efficiency, consistency and quality of tissue diagnostics and medical image analysis across a variety of fields from oncology to neuroscience. Aiforia’s mission is to provide the highest quality solutions for AI-assisted image analysis to enable personalized and democratized care for patients.
For more information, please contact:
Aiforia Media:
Emma Vehviläinen
Head of Marketing
Email: emma.vehvilaninen@aiforia.com